Physician profile
Yitzhack Asulin
NPI 1073752556
$10,721.35
in general payments reported to CMS, 2019-2025
35 companies · $293 in 2025
The $293 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,258 · 2020: $1,491 · 2021: $1,460 · 2022: $4,316 · 2023: $832 · 2024: $1,072 · 2025: $293.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,177 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,177.39 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asensus Surgical, INC. | $3,196.15 | 2020-2022 | |
| Medtronic, INC. | $1,740.12 | 2021-2025 | Interstim, Truclear |
| Axonics, INC. | $1,378.48 | 2021-2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $1,244.66 | 2019-2024 | |
| Abbvie INC. | $446.12 | 2019-2023 | Orilissa, Qulipta, Ubrelvy |
| Novo Nordisk INC | $398.37 | 2021-2025 | Wegovy |
| Caldera Medical, INC | $235.96 | 2022-2023 | Desara |
| Sumitomo Pharma America, INC. | $213.50 | 2023-2025 | Gemtesa, Myfembree |
| Pfizer INC. | $181.34 | 2023-2024 | |
| Myovant Sciences INC. | $138.03 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $130.56 | 2021-2023 | |
| Avion Pharmaceuticals | $127.25 | 2019-2021 | |
| Aspira Women'S Health INC | $126.63 | 2021 | |
| Medtronic USA, INC. | $119.98 | 2019-2020 | |
| Urovant Sciences INC | $115.16 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Momentis Surgical INC. | $95.25 | 2021 | |
| Lilly USA, LLC | $87.76 | 2021-2025 | Zepbound |
| Astellas Pharma US INC | $81.51 | 2019-2024 | Veozah |
| Ethicon US, LLC | $69.23 | 2019-2025 | Stratafix, Ethicon |
| Davol INC. | $64.99 | 2020-2021 | |
| Exeltis, USA INC. | $57.43 | 2020-2023 | Slynd |
| Coloplast Corp | $50.85 | 2020-2023 | Altis |
| Pacira Pharmaceuticals Incorporated | $47.89 | 2021-2022 | |
| Dysis Medical, INC. | $46.61 | 2021-2022 | |
| Meditrina | $43.53 | 2021-2023 | |
| Allergan, INC. | $43.47 | 2019-2022 | |
| Intra-Sana Laboratories | $41.65 | 2022-2025 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Merz North America, INC. | $41.37 | 2019 | |
| Hologic Sales and Service, LLC | $40.75 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $31.61 | 2025 | |
| Minerva Surgical, INC | $23.65 | 2019-2022 | |
| Conmed Corporation | $18.13 | 2024 | Airseal |
| Lsi Solutions INC | $15.12 | 2019 | |
| Baudax Bio INC. | $14.13 | 2020 | |
| Coopersurgical, INC. | $14.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yitzhack Asulin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.